MRMartin Rotter

Martin Rotter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martin Rotter has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact of Varying Ablation Patterns in a Simulation Model of Persistent Atrial Fibrillation

    by Martin Rotter, Lam Dang, Vincent Jacquemet, Nathalie Virag, Lukas Kappenberger, Michel Haïssaguerre

    Several strategies of endovascular ablation with varying success rates and proarrhythmic effects have been proposed to treat persistent atrial fibrillation (AF). Evaluation of ablation patterns by computer simulation provides a tool for examination of its effectiveness and side effects. A biophysical model of the human atria based on magnetic resonance imaging derived geometry and a membrane kinetics model was used. Uniform conduction properties were assigned to the monolayer surface representing the atria. After induction of AF by burst pacing, progressively broader ablation patterns were applied: (A) individual pulmonary vein isolation (PVI); (B) double ipsilateral PVI; (C) double PVI with a roofline; (D) double PVI with a lateral mitral isthmus line, and (E) double PVI with both linear lesions. In addition, the influence of incomplete linear lesions and dilated atria were simulated. The incidence of AF termination was found to increase from pattern (A) to (E). Atrial flutter rate increased with incomplete ablations and in dilated atria. Computer simulation of various ablation patterns in persistent AF is feasible and can reproduce clinical results of catheter ablation. This model can be used to develop and simulate new ablation patterns and anticipate success rates and potential adverse effects.


  • Decline in C-Reactive Protein After Successful Ablation of Long-Lasting Persistent Atrial Fibrillation

    by Martin Rotter, Pierre Jaïs, Marie-Christine Vergnes, Paquita Nurden, Yoshihide Takahashi, Prashanthan Sanders, Thomas Rostock, Mélèze Hocini, Fréderic Sacher, Michel Haïssaguerre


  • Clinical Predictors of Noninducibility of Sustained Atrial Fibrillation After Pulmonary Vein Isolation

    by Martin Rotter, Pierre Jaïs, Stephane Garrigue, Prashanthan Sanders, Mélèze Hocini, Li‐Fern Hsu, Yoshihide Takahashi, Thomas Rostock, Fréderic Sacher, Jacques Clementy, et al.

    The definitive version is available at www.blackwell-synergy.comBACKGROUND: Noninducibility of sustained atrial fibrillation (AF) after pulmonary vein isolation (PVI) has been shown to be associated with a better clinical outcome. We evaluated the role of clinical variables that could predict noninducibility of sustained AF after PVI. METHODS AND RESULTS: Data were collected prospectively from 181 patients (153 male; age 54 +/- 9 years) referred for ablation of drug-refractory symptomatic paroxysmal AF (duration < or =7 days). Clinical variables were evaluated with regard to their ability of predicting noninducibility of sustained AF (< or =10 minutes) after PVI. Univariate analysis was performed on all collected variables followed by multivariate analysis for variables showing a P value <0.1. After PVI, sustained AF was noninducible in 97 (54%) patients. The following clinical variables showed a significant difference between the groups: body weight, longest AF episode, duration of AF history, presence or absence of structural heart disease, left ventricular (LV) hypertrophy, prior cardioversion, left atrial (LA) parasternal, and longitudinal diameters and LV diameters. On multivariate analysis, three independent predictors of noninducibility were identified: a shorter duration of AF episodes (AF <12 hours: RR 0.01 (0.002-0.06), P < 0.001; AF 12-48 hours: RR 0.07 (0.01-0.37), P = 0.001); LA longitudinal diameter <57 mm (RR 0.33 (0.13-0.82), P = 0.016); and absence of LV hypertrophy (RR 0.15 (0.04-0.63), P = 0.01). CONCLUSIONS: Shorter AF episodes, smaller LA longitudinal diameter, and absence of LV hypertrophy are independent predictors of noninducibility of sustained AF after PVI.Martin Rotter, Pierre Jaîs, Stephane Garrigue, Prashanthan Sanders, Mélèze Hocini, Li-Fern Hsu, Yoshihide Takahashi, Thomas Rostock, Fréderic Sacher, Jacques Clémenty, and Michel Haîssaguerr


  • Prospective validation of phased array intracardiac echocardiography for the assessment of atrial mechanical function during catheter ablation of atrial fibrillation

    by M Rotter, P Sanders, P Jaïs, M Hocini, Y Takahashi, L-F Hsu, F Sacher, T Rostock, M Haïssaguerre

    This study enrolled 23 patients (20 men; mean (SD) age 56 (12) years) undergoing ablation of symptomatic drug refractory AF: 11 patients with paroxysmal and 12 with persistent AF of > 6 months’ duration. The left anteroposterior atrial size was 45 (8) mm and left ventricular ejection fraction was 63 (13)%. All patients were prospectively enrolled after providing written informed consent.


    • 1 April 2005
      • Vol. 53  (2) , 109-15

    Echocardiographic advances in atrial fibrillation and supraventricular arrhythmias.

    by M Rotter, P Jaïs, P Sanders, Y Takahashi, T Rostock, F Sacher, M Hocini, L F Hsu, J Clementy, M Haïssaguerre

    Advances in echocardiography have paved the way for the development of intracardiac catheters with ultrasound transducers mounted on its tip. With this technology it has become possible for the interventional electrophysiologist to perform continuous echocardiographic examination during a procedure without the need for general anaesthesia or additional staff. Intracardiac echocardiography (ICE) allows the monitoring of catheter movement in real-time, assessment of catheter-tissue contact and potentially prevents and recognizes complications like thrombus formation and pericardial effusion. In addition recent technologies allow acquiring the full spectrum of Doppler-imaging permitting evaluation of haemodynamic data during the procedure. All these advances have made ICE an ideal tool for the interventional electrophysiologist, serving as a diagnostic and imaging tool during invasive electrophysiological procedures. This review will summarize currently available technology of ICE and its indications and applications in electrophysiological procedures.


  • Correlation of atrial electrocardiographic amplitude with radiofrequency energy required to ablate cavotricuspid isthmus-dependent atrial flutter

    by Martin Rotter, Christophe Scavée, Fréderic Sacher, Prashanthan Sanders, Yoshihide Takahashi, Li-Fern Hsu, Thomas Rostock, Mélèze Hocini, Pierre Jaïs, Jacques Clementy, et al.


  • Coronary Sinus Tachycardia Driving Atrial Fibrillation

    by Martin Rotter, Prashanthan Sanders, Yoshihide Takahashi, Li-Fern Hsu, Frederic Sacher, MélÈzE Hocini, Pierre Jaïs, Michel HaïsSaguerre

    Images in cardiovascular medicineRotter, Martin; Sanders, Prashanthan; Takahashi, Yoshihide; Hsu, Li-Fern; Sacher, Frederic; Hocini, Mélèze; Jaïs, Pierre; Haïssaguerre, Miche


    • 1 June 2004
      • Vol. 52  (3) , 171-81

    Mapping and ablation of ventricular fibrillation.

    by P Sanders, L F Hsu, M Hocini, P Jaïs, Y Takahashi, M Rotter, F Sacher, J L Pasquié, T Arentz, C Scavée, et al.

    Sudden cardiac death frequently results from ventricular fibrillation (VF). While VF is frequently the eventual mode of death in patients with abnormal ventricular substrates, it has also been described in patients with structurally normally hearts. Until recently, the management of patients who have survived sudden cardiac death has focused on treating the consequences by implantation of a defibrillator. However, such therapy remains restricted in many countries, is associated with a prohibitive cost to the community, and may be a cause of significant morbidity in patients with frequent episodes or storms of arrhythmia. Evidence emerging from the study of fibrillation both in the atria and the ventricle suggests an important role for triggers arising from the Purkinje network or the right ventricular outflow tract in the initiation of VF. Initial experience in patients with idiopathic VF and even those with VF associated with abnormal repolarization syndromes (LQT or Brugada syndrome) or myocardial infarction suggests that long term suppression of recurrent VF may be feasible by the elimination of these triggers. With the development of new mapping and ablation technologies, and greater physician experience, catheter ablation of VF, with the ultimate aim of curing such patients at risks of sudden cardiac death, may not be an unrealistic goal in the future.